Search hospitals > Michigan > Grand Rapids
START Midwest
Claim this profileGrand Rapids, Michigan 49546
Global Leader in Solid Tumors
Global Leader in Uterine Tumors
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
113 reported clinical trials
6 medical researchers
Summary
START Midwest is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Solid Tumors, Uterine Tumors, Non-Small Cell Lung Cancer, Lung Cancer, Cancer and other specialties. START Midwest is involved with conducting 113 clinical trials across 174 conditions. There are 6 research doctors associated with this hospital, such as Nehal Lakhani, MD, Manish Sharma, MD, Katie Robinson, MD, and Sreenivasa Chandana, M.D., Ph.D..Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Uterine Tumors
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Nehal Lakhani, MDSTART Midwest5 years of reported clinical research
Expert in Uterine Tumors
Studies Solid Tumors
25 reported clinical trials
30 drugs studied
Manish Sharma, MDSTART Midwest6 years of reported clinical research
Expert in Solid Tumors
Studies Lung Cancer
19 reported clinical trials
30 drugs studied
Katie Robinson, MDSouth Texas Accelerated Research Therapeutics Midwest5 years of reported clinical research
Studies Skin Cancer
Studies Breast Cancer
6 reported clinical trials
9 drugs studied
Sreenivasa Chandana, M.D., Ph.D.START Midwest5 years of reported clinical research
Studies Stomach Cancer
Studies Biliary Tract Cancer
6 reported clinical trials
21 drugs studied
Clinical Trials running at START Midwest
Solid Tumors
Uterine Tumors
Non-Small Cell Lung Cancer
Ovarian Cancer
Lung Cancer
Colorectal Cancer
Skin Cancer
Breast Cancer
Cancer
Pancreatic Cancer
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
AU-007
for Advanced Cancer
This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w). Once the recommended phase 2 dose (RP2D) of AU-007 plus aldesleukin was determined, (AU-007 Q2w plus a single loading dose of aldesleukin), AU-007 plus aldesleukin is also being administered with avelumab or nivolumab.
Recruiting1 award Phase 1 & 28 criteria
ART6043
for Metastatic Cancer
This trial tests a new cancer drug, ART6043, alone or with other drugs (Olaparib and Niraparib) in patients with advanced cancers that have genetic defects in DNA repair. The treatment aims to exploit the cancer cells' inability to fix their DNA, making it harder for them to survive. Olaparib is used to treat certain cancers by preventing the cancer cells from fixing their DNA, which makes it harder for them to survive.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at START Midwest?
START Midwest is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Solid Tumors, Uterine Tumors, Non-Small Cell Lung Cancer, Lung Cancer, Cancer and other specialties. START Midwest is involved with conducting 113 clinical trials across 174 conditions. There are 6 research doctors associated with this hospital, such as Nehal Lakhani, MD, Manish Sharma, MD, Katie Robinson, MD, and Sreenivasa Chandana, M.D., Ph.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.